BIORA THERAPEUTICS INC - COM NEW (BIOR)

CUSIP: 74319F305

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM NEW
Total 13F shares
2,332,290
Share change
+2,332,290
Total reported value
$6,458,638
Put/Call ratio
15%
Price per share
$2.77
Number of holders
28
Value change
+$6,458,638
Number of buys
28

Quarterly Holders Quick Answers

What is CUSIP 74319F305?
CUSIP 74319F305 identifies BIOR - BIORA THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIORA THERAPEUTICS INC - COM NEW (BIOR) as of Q1 2023

As of 31 Mar 2023, BIORA THERAPEUTICS INC - COM NEW (BIOR) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,332,290 shares. The largest 10 holders included Athyrium Capital Management, LP, VANGUARD GROUP INC, BlackRock Inc., GSA CAPITAL PARTNERS LLP, GEODE CAPITAL MANAGEMENT, LLC, Schonfeld Strategic Advisors LLC, Creative Planning, LPL Financial LLC, STATE STREET CORP, and BRIDGEWAY CAPITAL MANAGEMENT, LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.